Old Web
English
Sign In
Acemap
>
Paper
>
The Use of CD4+CD127lo/-CD25+ Polyclonal Tregs for the Treatment of Recent Onset T1D in a Phase I Clinical Trial
The Use of CD4+CD127lo/-CD25+ Polyclonal Tregs for the Treatment of Recent Onset T1D in a Phase I Clinical Trial
2010
Amy L. Putnam
Michael R. Lee
Weihong Liu
Heather Escosa
Todd M. Brusko
Jeffrey A. Bluestone
Keywords:
Polyclonal antibodies
Immunology
Biology
IL-2 receptor
Virology
Phases of clinical research
recent onset
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]